Table 1 Patients’ baseline demographics by study group
All n = 40 | Treatment group n = 20 | Control group n = 20 | P value | |
|---|---|---|---|---|
Median (IQR) | Median (IQR) | Median (IQR) | ||
Sex (male/female) | 19/1 | 19/1 | ||
Age (years) | 38.0(30.0–47.5) | 34.5(29.3–43.0) | 39.0(31.5–49.0) | 0.198 |
Body height (cm) | 170.50(166.0–175.8) | 171.0(168.0–175.0) | 169.0(165.0–178.8) | 0.655 |
Body weight (kg) | 76.2(68.5–90.0) | 76.2(72.3–88.3) | 76.0(65.8–91.5) | 0.797 |
BMI (kg/m2) | 26.4(24.2–29.1) | 26.5(24.2–29.0) | 26.4(23.8–29.3) | 0.978 |
SBP (mmHg) | 130.0(122.3–139.8) | 126.0(121.3–136.8) | 132.5(126.5–141.5) | 0.163 |
DBP (mmHg) | 84.0(72.8–88.0) | 81.0(70.3–88.0) | 85.0(79.3–88.8) | 0.302 |
WBC (/μl) | 8725(7125–10275) | 8910(7515–10115) | 8725(6622–10525) | 0.776 |
RBC (104/μl) | 520.5(480–535) | 525.0(491.3–556.5) | 501.0(468.3–528.8) | 0.079 |
Hb (g/dl) | 14.9(14.3–15.7) | 15.1(14.0–16.1) | 14.8(14.3–15.7) | 0.871 |
Hct (%) | 44.0(41.8–45.8) | 43.9(41.5–46.6) | 44.1(42.6–45.7) | 0.685 |
MCV (fl) | 87.0(84.3–90.3) | 85.8(83.4–87.6) | 87.8(85.7–92.0) | 0.022 |
MCH (Pg) | 29.4(29.0–30.7) | 29.4(28.8–30.1) | 30.4(29.1–31.0) | 0.104 |
MCHC (g/dl) | 33.9(33.5–34.5) | 34.2(33.5–34.8) | 33.7(33.5–34.3) | 0.316 |
Platelet (/μl) | 236.5 K(211 K–267.5 K) | 243.5 K(205 K–261.5 K) | 234.5 K(212 K–269 K) | 0.756 |
GPT (IU/l) | 29.5(17.0–41.8) | 31.0(13.8–37.0) | 28.0(17.0–43.8) | 0.498 |
Creatine (mg/dl) | 1.00(0.9–1.1) | 1.0(0.9–1.1) | 0.9(0.8–1.0) | 0.182 |
CRP (mg/dl) | 0.6(0.2–1.7) | 0.5(0.2–1.3) | 0.7(0.5–1.9) | 0.351 |
Uric acid (mg/dl) | 7.3(5.9–8.3) | 7.3(5.9–8.3) | 7.4(5.9–8.4) | 0.892 |
VAS | 5.0(3.0–8.0) | 5.5(3.6, 9.0) | 5.0(3.0–7.0) | 0.241 |